BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10575542)

  • 21. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.
    Hanson EH; Imperatore G; Burke W
    Am J Epidemiol; 2001 Aug; 154(3):193-206. PubMed ID: 11479183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.
    Thorstensen K; Asberg A; Kvitland M; Svaasand E; Hveem K; Bjerve KS
    Genet Test; 2000; 4(4):371-6. PubMed ID: 11216661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation.
    Tordai A; Andrikovics H; Kalmár L; Rajczy K; Pénzes M; Sarkadi B; Klein I; Váradi A
    J Med Genet; 1998 Oct; 35(10):878-9. PubMed ID: 9783719
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.
    Santos M; Clevers HC; Marx JJ
    N Engl J Med; 1997 May; 336(18):1327-8. PubMed ID: 9132598
    [No Abstract]   [Full Text] [Related]  

  • 25. The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region.
    Mortimore M; Merryweather-Clarke AT; Robson KJ; Powell LW
    J Gastroenterol Hepatol; 1999 Sep; 14(9):838-43. PubMed ID: 10535463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
    Barton EH; West PA; Rivers CA; Barton JC; Acton RT
    Blood Cells Mol Dis; 2001; 27(1):279-84. PubMed ID: 11358388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overestimation of HFE C282Y homozygous hemochromatosis prevalence as the result of a common primer-binding site polymorphism.
    Press RD
    Mol Diagn; 1999 Dec; 4(4):391-2. PubMed ID: 10671650
    [No Abstract]   [Full Text] [Related]  

  • 28. Celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 1998 Dec; 24(4):433-8. PubMed ID: 9851897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient large-scale screening for the hemochromatosis susceptibility gene mutation.
    Takeuchi T; Soejima H; Faed JM; Yun K
    Blood; 1997 Oct; 90(7):2848-9. PubMed ID: 9326257
    [No Abstract]   [Full Text] [Related]  

  • 30. HFE genotyping: maximising the value for hemochromatosis patients and families.
    Bassett ML
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1186-8. PubMed ID: 20594244
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis?
    Jouanolle AM; Fergelot P; Raoul ML; Gandon G; Roussey M; Deugnier Y; Feingold J; Le Gall JY; David V
    Ann Genet; 1998; 41(4):195-8. PubMed ID: 9881181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HFE, iron homeostasis and genetic hemochromatosis.
    Cazzola M
    Haematologica; 2000 Apr; 85(4):338-9. PubMed ID: 10756355
    [No Abstract]   [Full Text] [Related]  

  • 33. HFE gene mutation, C282Y causing hereditary hemochromatosis in Caucasian is extremely rare in Korean population.
    Lee JY; Yoo KH; Hahn SH
    J Korean Med Sci; 2000 Apr; 15(2):179-82. PubMed ID: 10803694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
    Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
    Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas.
    Martinez di Montemuros F; Tavazzi D; Salsano E; Piepoli T; Pollo B; Fiorelli G; Finocchiaro G
    Neurology; 2001 Oct; 57(7):1342. PubMed ID: 11591868
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of histone family E1 (HFE) mutant alleles in a Tamilian cohort from Vellore, South India.
    Danda S; Eapen CE; Kuruvilla KA; Santhosh S; Kurian G; Chandy GM
    Indian J Med Sci; 2010 May; 64(5):242-4. PubMed ID: 22842326
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemochromatosis and HLA-H.
    Jazwinska EC; Cullen LM; Busfield F; Pyper WR; Webb SI; Powell LW; Morris CP; Walsh TP
    Nat Genet; 1996 Nov; 14(3):249-51. PubMed ID: 8896549
    [No Abstract]   [Full Text] [Related]  

  • 38. Multicentric origin of hemochromatosis gene (HFE) mutations.
    Rochette J; Pointon JJ; Fisher CA; Perera G; Arambepola M; Arichchi DS; De Silva S; Vandwalle JL; Monti JP; Old JM; Merryweather-Clarke AT; Weatherall DJ; Robson KJ
    Am J Hum Genet; 1999 Apr; 64(4):1056-62. PubMed ID: 10090890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hemochromatosis gene.
    Leber BF
    Clin Invest Med; 2000 Dec; 23(6):382-6. PubMed ID: 11152407
    [No Abstract]   [Full Text] [Related]  

  • 40. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations.
    Merryweather-Clarke AT; Simonsen H; Shearman JD; Pointon JJ; Nørgaard-Pedersen B; Robson KJ
    Hum Mutat; 1999; 13(2):154-9. PubMed ID: 10094552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.